Business Wire

Ant Group 2024 Sustainability Report Highlights AI-Powered Digital Inclusion and New Initiatives From 3 Independent Units

30.6.2025 12:54:00 EEST | Business Wire | Press release

Share

Ant Group today published its 2024 Sustainability Report, highlighting its enhanced AI investments in advancing broad-based digital transformation. The report also shares how the group's sustainability commitments are carried onto new journeys of Ant International, Ant Digital Technologies, and OceanBase, three units that became independent following the 2024 reorganization.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250629805132/en/

The Report lays out how Ant Group harnessed new technology tools, expanded partnerships in 2024 to strengthen its 4 sustainability pillars: Technological Innovation, AI-Powered Digital Inclusion, Green and Low-Carbon Development, and Openness & Trustworthiness.

“2024 marks the 20th anniversary of Alipay and Ant Group. Over the past two decades, we have remained committed to leveraging innovation to make quality services more accessible for small entrepreneurs and ordinary consumers, so that the business and the life they treasure may flourish because of the work we do,” wrote Eric Jing, Chairman of Ant Group and Cyril Han, CEO of Ant Group in a letter at the beginning of the Report. “Technology matters not only when it soars above the stars, but even more when it puts light and warmth across our streets and neighborhoods. At the dawn of the age of AI, we are empowered to do more and better for small businesses and individuals.”

Technological Innovation

To drive continuous innovation for consumers, SMEs and partners, Ant Group has increased R&D investment for four consecutive years since 2021, reaching a record high of RMB 23.45 billion (~USD 3.26 billion) in 2024 (up 10.7% YoY).1

  • 130 million users have accessed the Company’s AI-powered services connecting them with providers in healthcare, finance and everyday services. (43% from lower-tier cities)
  • 24,000+ businesses adopted Ant’s enterprise solutions (AI, blockchain, distributed databases) to improve operational efficiency.
  • 2,000+ open-source repositories released to support developers.

AI-Powered Digital Inclusion

In 2024, Ant Group has made AI-powered services more accessible for its users, in sectors including healthcare, fintech and cross-border commerce.

AI healthcare solutions for hospitals, doctors and users

  • By harnessing AI, Ant Group has been enhancing operational efficiency, personalizing patient care, and empowering medical institutions, doctors, and insurers to deliver more effective and tailored healthcare solutions.
  • AI healthcare app “AQ”: 70 million+ users by June 2025.
  • AI medical insurance assistant: 80% faster claim processing for insurers.

Digital payment & finance for SMEs

  • With digital payment and finance innovation, Ant Group, together with its affiliates, has served more than 100 million SMEs.
  • Following QR code payment in 2011 and Smile-to-Pay in 2018, Ant Group launched Alipay Tap! in July 2024, a QR code-based contactless payment and customer engagement solution. As of April 2025, Alipay Tap! has won over 100 million users in just 11 months. FamilyMart’s member orders rose by 40% within the first month of Alipay Tap! integration.
  • Alipay’s AI-enhanced merchant services further reduce costs and boost efficiency. In 2024, the annual transaction volume of merchant operated mini-programs grew 39% YoY.

New advances in sustainability from 3 independently operated businesses

Ant Digital Technologies, OceanBase and Ant International, the three businesses that have been operating independently since 2024 have been making steady progress in sustainability.

Supporting the digital & green transformation of industries - Ant Digital Technologies:

  • AntChain's trusted on-chain technology has been widely applied across the new energy sector, including electric vehicles, batteries, and photovoltaic panels, with over 12 million devices cumulatively connected to its blockchain.
  • In December 2024, GCL Energy Technology Co., Ltd., a leader in the clean energy sector successfully completed the first-ever Real World Asset Tokenization (RWA) issuance in China's photovoltaic industry, securing 200 million yuan in cross-border financing, proving that physical assets can be digitized and financed on the blockchain.

Making AI-ready distributed database accessible for enterprise clients - OceanBase:

  • Expanded number of clients from over 1,000 to over 2,000 (100% YoY).
  • Distributed database products have been upgraded to meet the database demand of the AI era, widely adopted across industries including finance, telecommunications, retail, Internet, and public services.

Enabling global connections in travel, empowering global commerce in trade and enabling the underserved to thrive - Ant International:

  • In travel, Alipay+ has enabled inclusive and affordable payment options for more than 100 million businesses in over 70 tourist destination markets.
  • In trade, WorldFirst has enabled over 1.2 million SMEs to sell their products and services across more than 200 markets with its one-stop cross-border account and treasury services.
  • In 2024, AI-powered Credit Tech solutions, ANEXT Bank and Ant Bank (Hong Kong) helped extend lending and other inclusive financial services to over 15 million users in emerging markets, mostly from the SME community.
  • For more details on Ant International’s sustainability progress, please refer to Ant International 2024 Sustainability Report.

“Integrating commercial and social value creation isn't just our choice when we started – it is our guiding North Star,” wrote Sabrina Peng, Chief Sustainability Officer of Ant Group. “Meaningful change grows in daily action, not in words. By integrating commercial and social value creation, we hope to do our part in building a better world – especially for the general public and small businesses.”

Note: Since 2017, Ant Group has been publishing an annual sustainability report, following the Global Reporting Initiative standards. All figures in the release are as of December 31, 2024 unless otherwise specified. The 2024 Sustainability Report is available in Chinese. The English-language version will be available on Ant Group’s official website soon.

About Ant Group

Ant Group aims to build the infrastructure and platforms to support the digital transformation of the service industry. Through continuous innovation, we strive to provide all consumers and small and micro businesses equal access to digital financial and other daily life services that are convenient, sustainable and inclusive.

For more information, please visit our website at www.antgroup.com or follow us on Twitter @AntGroup.

1 Source: Ant Group Sustainability Reports (2022 to 2024)

View source version on businesswire.com: https://www.businesswire.com/news/home/20250629805132/en/

Contacts

Media inquiries:
Rosa Lei
leiyutian.lyt@antgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye